155 related articles for article (PubMed ID: 14556778)
21. Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant.
Martino R; Caballero MD; de la Serna J; Díez-Martín JL; Urbano-Ispízua A; Tomás JF; Odriozola J; León A; Canals C; San Miguel J; Sierra J
Bone Marrow Transplant; 2002 Jul; 30(2):63-8. PubMed ID: 12132043
[TBL] [Abstract][Full Text] [Related]
22. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
Mancardi GL; Sormani MP; Di Gioia M; Vuolo L; Gualandi F; Amato MP; Capello E; Currò D; Uccelli A; Bertolotto A; Gasperini C; Lugaresi A; Merelli E; Meucci G; Motti L; Tola MR; Scarpini E; Repice AM; Massacesi L; Saccardi R;
Mult Scler; 2012 Jun; 18(6):835-42. PubMed ID: 22127896
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis.
Xu J; Ji BX; Su L; Dong HQ; Sun XJ; Liu CY
Chin Med J (Engl); 2006 Nov; 119(22):1851-5. PubMed ID: 17134581
[TBL] [Abstract][Full Text] [Related]
24. A Feasibility Study of the Full Outpatient Conduction of Hematopoietic Transplants in Persons with Multiple Sclerosis Employing Autologous Non-Cryopreserved Peripheral Blood Stem Cells.
Ruiz-Argüelles GJ; León-Peña AA; León-González M; Nuñez-Cortes AK; Olivares-Gazca JC; Murrieta-Alvarez I; Vargas-Espinosa J; Medina-Ceballos E; Cantero-Fortiz Y; Ruiz-Argüelles A; Ruiz-Delgado MA; Ruiz-Delgado RJ; Ruiz-Reyes G; Priesca-Marín M; Torres-Priego MS; Blumenkron-Marroquin D; Ruiz-Delgado GJ
Acta Haematol; 2017; 137(4):214-219. PubMed ID: 28514773
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.
Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA
Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670
[TBL] [Abstract][Full Text] [Related]
26. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
Burt RK; Loh Y; Cohen B; Stefoski D; Balabanov R; Katsamakis G; Oyama Y; Russell EJ; Stern J; Muraro P; Rose J; Testori A; Bucha J; Jovanovic B; Milanetti F; Storek J; Voltarelli JC; Burns WH
Lancet Neurol; 2009 Mar; 8(3):244-53. PubMed ID: 19186105
[TBL] [Abstract][Full Text] [Related]
27. Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation.
Villela L; Sureda A; Canals C; Sanz MA; Martino R; Valcárcel D; Altés A; Briones J; Gómez M; Brunet S; Sierra J
Haematologica; 2003 Mar; 88(3):300-5. PubMed ID: 12651269
[TBL] [Abstract][Full Text] [Related]
28. [Intensive treatment of multiple myeloma].
Harousseau JL
Bull Acad Natl Med; 2003; 187(2):405-13; discussion 413-5. PubMed ID: 14556449
[TBL] [Abstract][Full Text] [Related]
29. Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis.
Mancardi GL; Murialdo A; Rossi P; Gualandi F; Martino G; Marmont A; Ciceri F; Schenone A; Parodi RC; Capello E; Comi G; Uccelli A
Mult Scler; 2005 Jun; 11(3):367-71. PubMed ID: 15957523
[TBL] [Abstract][Full Text] [Related]
30. Stem cell transplantation for autoimmune disorders. Multiple sclerosis.
Fassas A; Nash R
Best Pract Res Clin Haematol; 2004 Jun; 17(2):247-62. PubMed ID: 15302338
[TBL] [Abstract][Full Text] [Related]
31. High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma.
Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
Leuk Lymphoma; 2006 Aug; 47(8):1545-52. PubMed ID: 16966265
[TBL] [Abstract][Full Text] [Related]
32. Second autologous transplant as salvage therapy in multiple myeloma.
Atanackovic D; Schilling G
Br J Haematol; 2013 Dec; 163(5):565-72. PubMed ID: 24111632
[TBL] [Abstract][Full Text] [Related]
33. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
34. Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study.
Curro' D; Vuolo L; Gualandi F; Bacigalupo A; Roccatagliata L; Capello E; Uccelli A; Saccardi R; Sormani MP; Mancardi G
Mult Scler; 2015 Oct; 21(11):1423-30. PubMed ID: 25583838
[TBL] [Abstract][Full Text] [Related]
35. High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Kyriakou C; Canals C; Sibon D; Cahn JY; Kazmi M; Arcese W; Kolbe K; Gorin NC; Thomson K; Milpied N; Niederwieser D; Indrák K; Corradini P; Sureda A; Schmitz N
J Clin Oncol; 2010 May; 28(13):2227-32. PubMed ID: 20368570
[TBL] [Abstract][Full Text] [Related]
36. Clinical and quality of life responses to high-dose chemotherapy plus autologous stem cell transplantation in patients with multiple sclerosis: two case reports.
Novik AA; Ionova TI; Bisaga GN; Kishtovich AV; Fedorenko DA; Ivanov RA; Gorodokin GI
Cytotherapy; 2005; 7(4):363-7. PubMed ID: 16162458
[TBL] [Abstract][Full Text] [Related]
37. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
38. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center.
Ozdogu H; Boga C; Kizilkilic E; Kozanoglu I; Karakus S; Sahin FI; Unalan D; Haberal M
Transplant Proc; 2007 May; 39(4):1257-60. PubMed ID: 17524948
[TBL] [Abstract][Full Text] [Related]
39. Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis.
Sormani MP; Muraro PA; Schiavetti I; Signori A; Laroni A; Saccardi R; Mancardi GL
Neurology; 2017 May; 88(22):2115-2122. PubMed ID: 28455383
[TBL] [Abstract][Full Text] [Related]
40. Stem cell transplantation for autoimmune diseases.
Gratwohl A; Passweg J; Gerber I; Tyndall A;
Best Pract Res Clin Haematol; 2001 Dec; 14(4):755-76. PubMed ID: 11924920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
